An Act to amend and reenact § 32.1-68 of the Code of Virginia, relating to sickle cell disease education and screening program; cancer risk.
HB392 amends Virginia Code § 32.1-68, which governs the state’s voluntary sickle cell screening and education program. The bill keeps the existing framework for screening adults and children for sickle cell anemia, sickle cell trait, and related genetic conditions, but expands the required educational component to include information about cancers that are more common in people with sickle cell disease or the sickle cell trait, including certain kidney cancers.
The measure also directs the program to provide culturally and linguistically appropriate educational resources to health care providers, affected individuals, and families. Those materials must cover cancer risks, warning signs and symptoms, surveillance, referral resources for treatment, and the importance of communicating concerns to providers. The bill further preserves the Board’s authority to update screening methods and requires regulations for an adult and pediatric comprehensive sickle cell clinic network.
The bill amends § 32.1-68 of the Code of Virginia by broadening the scope of the state’s sickle cell education and screening program. It does not create a mandatory screening requirement, but it adds new educational duties for the Commissioner and the Board of Health, and it reinforces the state’s role in coordinating provider education, counseling, and clinic-network regulations. The affected parties include health care providers who screen for sickle cell conditions, individuals with sickle cell disease or trait, and their families, who would receive expanded information about cancer risk and follow-up care.
The available record shows no committee transcript, vote tally, or recorded opposition, so there is no direct evidence of controversy in the materials provided. Based on the bill’s content, the general sentiment appears supportive and public-health oriented, focusing on education, awareness, and improved counseling for patients and providers. The bill was enacted as Chapter 600, which suggests it moved successfully through the legislative process.
No specific points of contention are documented in the provided transcripts or votes. Any potential concerns would likely center on the scope of the new educational mandate, the accuracy and breadth of cancer-risk information, and the administrative burden on the health department and screening providers. However, the bill text itself is framed as an expansion of education and resource-sharing rather than a regulatory or funding-heavy mandate, and no opposing viewpoints are recorded in the supplied materials.